نتایج جستجو برای: disease prophylaxis

تعداد نتایج: 1510917  

Journal: :Archives of pediatrics & adolescent medicine 2006
Nahed O Elhassan Melony E S Sorbero Caroline B Hall Timothy P Stevens Andrew W Dick

OBJECTIVES To evaluate the cost-effectiveness of palivizumab as respiratory syncytial virus prophylaxis in premature infants without chronic lung disease and to evaluate the impact on cost-effectiveness of a potential reduction in risk of asthma following respiratory syncytial virus infection among infants receiving palivizumab. DESIGN Two decision analytic models were designed, one with and ...

Journal: :AIDS 1998
A M Bayoumi D A Redelmeier

BACKGROUND Practice guidelines recommending Mycobacterium avium complex (MAC) prophylaxis for patients with HIV disease were based on clinical trials in which individuals did not receive protease inhibitors. OBJECTIVE To estimate the cost-effectiveness of strategies for MAC prophylaxis in patients whose treatment regimen includes protease inhibitors. DESIGN Decision analysis with Markov mod...

Journal: :Archivos argentinos de pediatria 2015
Silvina Ruvinsky Moira Taicz M Guadalupe Pérez Andrea Mónaco Natalia García Escudé Laura Inda Mirta Carbonaro Rosa Bologna

INTRODUCTION Casa Garrahan (CG) accommodates children with complex conditions referred nationwide; these children are seen in children's hospitals located in the Autonomous City of Buenos Aires. Varicella is a highly-contagious disease, with attack rates of up to 90% among susceptible individuals. In closed communities, the implementation of outbreak control measures is critical. OBJECTIVES T...

Journal: :Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006
Jeong M Park Kathleen D Lake Juan D Arenas Robert J Fontana

The efficacy and safety of valganciclovir (VGCV) for cytomegalovirus (CMV) prophylaxis in liver transplant recipients has not been established. We retrospectively compared the efficacy and safety of low-dose oral VGCV (450 mg once daily for 90 days) and standard oral ganciclovir (1 g three times a day for 90 days, GCV) in preventing CMV disease in 109 adult liver transplant recipients who survi...

Journal: :American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010
A Humar Y Lebranchu F Vincenti E A Blumberg J D Punch A P Limaye D Abramowicz A G Jardine A T Voulgari J Ives I A Hauser P Peeters

Late-onset cytomegalovirus (CMV) disease is a significant problem with a standard 3-month prophylaxis regimen. This multicentre, double-blind, randomized controlled trial compared the efficacy and safety of 200 days' versus 100 days' valganciclovir prophylaxis (900 mg once daily) in 326 high-risk (D+/R-) kidney allograft recipients. Significantly fewer patients in the 200-day group versus the 1...

Journal: :Haematologica 1999
M Marchetti N L Liberato N Ruperto G Barosi

BACKGROUND AND OBJECTIVE Either low molecular weight heparin (LMWH) or unfractionated heparin (UH) may be used for the prophylaxis of post-operative venous thromboembolic disease (VTD) in elective hip replacement. This study was aimed at assessing the cost-effectiveness of LMWH over UH from the society perspective, which considers all the outcomes occurring in the life-long time horizon. DESI...

2009
Kari S Anderson Victoria M Mullally Linda M Fredrick Andrew L Campbell

Respiratory syncytial virus (RSV) is a significant cause of morbidity in high-risk infants. Palivizumab is proven to prevent serious RSV disease, but compliance with prophylaxis (monthly doses during the RSV season) is essential to ensure protection. We invited 453 pediatricians to participate in a survey to identify their perspectives of barriers to compliance and interventions to improve comp...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016
Karen K Wong Richard T Davey Angela L Hewlett Colleen S Kraft Aneesh K Mehta Mark J Mulligan Allison Beck William Dorman Christopher J Kratochvil Lilin Lai Tara N Palmore Susan Rogers Philip W Smith Anthony F Suffredini Mark Wolcott Ute Ströher Timothy M Uyeki

From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.

Journal: :Anales de pediatria 2015
F Baquero-Artigao M J Mellado Peña T del Rosal Rabes A Noguera Julián A Goncé Mellgren M de la Calle Fernández-Miranda M L Navarro Gómez

In pregnant women who have been exposed to tuberculosis (TB), primary isoniazid prophylaxis is only recommended in cases of immunosuppression, chronic medical conditions or obstetric risk factors, and close and sustained contact with a patient with infectious TB. Isoniazid prophylaxis for latent tuberculosis infection (LTBI) is recommended in women who have close contact with an infectious TB p...

Memar , N,

ABSTRACT This is a descriptive-analytic survey to evaluation the knowledge of women and men over 15 years old about prophylaxis and transferring of AIDS and hepatitis B in sanandaj in 1998. The purpose of this study was to determine knowledge of people over 15 years old about prophylaxis of AIDS and hepatitis B based on their age, job, and education. In this study 852 men and Women over 15 yr....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید